2009
DOI: 10.1189/jlb.0309203
|View full text |Cite
|
Sign up to set email alerts
|

Hyperactivated B cells in human inflammatory bowel disease

Abstract: IBD is characterized by a chronic, dysregulated immune response to intestinal bacteria. Past work has focused on the role of T cells and myeloid cells in mediating chronic gastrointestinal and systemic inflammation. Here, we show that circulating and tissue B cells from CD patients demonstrate elevated basal levels of activation. CD patient B cells express surface TLR2, spontaneously secrete high levels of IL-8, and contain increased ex vivo levels of phosphorylated signaling proteins. CD clinical activity cor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
70
0

Year Published

2010
2010
2013
2013

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 68 publications
(72 citation statements)
references
References 59 publications
2
70
0
Order By: Relevance
“…However, after transplantation, a small amount of allogeneic PDLSCs might be presented to B cells as antigen by antigen-presenting cells, and these B cells might be stimulated and express IL-6 and B7, which activated the PD-1/PD-L1 expression of MSCs in periodontal tissue. Previous studies suggest that activated human B cells can circulate throughout the body [47], so the B cells in inflamed periodontal tissue can be existed in situ or migrated from lymph nodes and other inflammatory tissues. After treatment, the allogeneic MSCs migrated followed CXCL12, CXCL13, and CCL19 density [11,48] toward the site of inflamed area, suppressed the chemotaxis in B cells.…”
Section: Discussionmentioning
confidence: 99%
“…However, after transplantation, a small amount of allogeneic PDLSCs might be presented to B cells as antigen by antigen-presenting cells, and these B cells might be stimulated and express IL-6 and B7, which activated the PD-1/PD-L1 expression of MSCs in periodontal tissue. Previous studies suggest that activated human B cells can circulate throughout the body [47], so the B cells in inflamed periodontal tissue can be existed in situ or migrated from lymph nodes and other inflammatory tissues. After treatment, the allogeneic MSCs migrated followed CXCL12, CXCL13, and CCL19 density [11,48] toward the site of inflamed area, suppressed the chemotaxis in B cells.…”
Section: Discussionmentioning
confidence: 99%
“…We thus assessed phospho (P)-kinases within the well-described BCR Ag capture signaling pathways for comparison with CD23 (20). Signaling through CD23 was similar in tonsil, peripheral blood, and Ramos B cells except for basal levels of P-ERK1/2, which we previously reported were higher in circulating B cells (22). AntiIgE, anti-CD23, and Ag-specific cross-linking of cell-bound IgE (Fig.…”
Section: Cd23mentioning
confidence: 92%
“…[19][20][21] These activated B cells can secrete significant amounts of cytokines and chemokines while in circulation. 19 However, systemic host-and microbial-derived TLR ligands can modify B-cell responses in a pro-or antiinflammatory manner. 22 This has been shown primarily by the differential responses of human B cells to TLR4 ligands.…”
mentioning
confidence: 99%